Latest News

Descemet’s stripping only shows promise in some Fuchs’ patients

PARIS — For some patients, the use of a topical Rho kinase inhibitor following a Descemet’s stripping only procedure for Fuchs’ dystrophy “can be life-changing,” Kathryn Colby, MD, PhD, said at EuCornea 2019.
Colby, who is chair of the department of ophthalmology and visual sciences at the University of Chicago, has been interested in this line of research since 2013, even though the idea was not well received in the cornea community at the time, she said.
Colby reported recent research in which 29 eyes of 23 patients were enrolled, and stripping size varied from 4

Source link

Related posts

The use of capacitance measurement in fermentation monitoring


Medical News Today: Why do people feel tired after eating?


Q&A: Vaccine controversies in the US


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy